NCT01558323View on ClinicalTrials.gov

Pharmacokinetics of LCQ908 in Patients With Renal Impairment

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Renal Impairment
Interventions
DRUG

LCQ908

Participants will receive a single oral dose of LCQ908

Trial Locations (2)

32809

Novartis Investigative Site, Orlando

37920

Novartis Investigative Site, Knoxville

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY